-
1
-
-
14944344464
-
-
10.1021/jm040158k
-
E. Clercq 2004 J. Med. Chem. 48 5 1297 1313 10.1021/jm040158k
-
(2004)
J. Med. Chem.
, vol.48
, Issue.5
, pp. 1297-1313
-
-
Clercq, E.1
-
4
-
-
24944540240
-
-
16182193 1:CAS:528:DC%2BD2MXpvVSmsbc%3D
-
H.J. Ryser P. Ryser R. Fluckiger 2005 DDT 10 16 1085 1094 16182193 1:CAS:528:DC%2BD2MXpvVSmsbc%3D
-
(2005)
DDT
, vol.10
, Issue.16
, pp. 1085-1094
-
-
Ryser, H.J.1
Ryser, P.2
Fluckiger, R.3
-
5
-
-
73549107210
-
-
19782103 10.1016/j.antiviral.2009.09.009 1:CAS:528:DC%2BC3cXnvFCguw%3D%3D
-
C.S. Adamson E.O. Freed 2010 Antiviral Res. 85 119 141 19782103 10.1016/j.antiviral.2009.09.009 1:CAS:528:DC%2BC3cXnvFCguw%3D%3D
-
(2010)
Antiviral Res.
, vol.85
, pp. 119-141
-
-
Adamson, C.S.1
Freed, E.O.2
-
6
-
-
73549092165
-
-
19683546 10.1016/j.antiviral.2009.07.022 1:CAS:528:DC%2BC3cXnvFClsg%3D%3D
-
J.C. Tilton R.W. Doms 2010 Antiviral Res. 85 91 100 19683546 10.1016/j.antiviral.2009.07.022 1:CAS:528:DC%2BC3cXnvFClsg%3D%3D
-
(2010)
Antiviral Res.
, vol.85
, pp. 91-100
-
-
Tilton, J.C.1
Doms, R.W.2
-
7
-
-
35148827436
-
-
S. Orsega 2007 JNP 10 612 624
-
(2007)
JNP
, vol.10
, pp. 612-624
-
-
Orsega, S.1
-
8
-
-
2442470533
-
-
15482105 10.1586/14787210.1.1.97 1:CAS:528:DC%2BD3sXlsFaisrk%3D
-
J.A. Turpin 2003 Expert Rev. Anti-Infect. Ther. 1 1 97 128 15482105 10.1586/14787210.1.1.97 1:CAS:528:DC%2BD3sXlsFaisrk%3D
-
(2003)
Expert Rev. Anti-Infect. Ther.
, vol.1
, Issue.1
, pp. 97-128
-
-
Turpin, J.A.1
-
9
-
-
33645982253
-
-
16611063 10.2174/092986706776055599 1:CAS:528:DC%2BD28XisVSqtbk%3D
-
K. Vermeire D. Schols T.W. Bell 2006 Curr. Med. Chem. 13 731 743 16611063 10.2174/092986706776055599 1:CAS:528:DC%2BD28XisVSqtbk%3D
-
(2006)
Curr. Med. Chem.
, vol.13
, pp. 731-743
-
-
Vermeire, K.1
Schols, D.2
Bell, T.W.3
-
10
-
-
80055020407
-
-
O.A. Tuchnaya O.V. Gorlachuk V.A. Livshits I.I. Kashiricheva N.S. Shastina A.M. Yurkevich V.I. Shvets 2008 Khim.-Farm. Zh. 42 1 65 71
-
(2008)
Khim.-Farm. Zh.
, vol.42
, Issue.1
, pp. 65-71
-
-
Tuchnaya, O.A.1
Gorlachuk, O.V.2
Livshits, V.A.3
Kashiricheva, I.I.4
Shastina, N.S.5
Yurkevich, A.M.6
Shvets, V.I.7
-
12
-
-
0029011730
-
-
10.1021/jm00014a001
-
E. Clercq 1995 J. Med. Chem. 8 14 2491 2517 10.1021/jm00014a001
-
(1995)
J. Med. Chem.
, vol.8
, Issue.14
, pp. 2491-2517
-
-
Clercq, E.1
-
13
-
-
34250188089
-
Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides
-
DOI 10.1016/j.antiviral.2007.03.004, PII S0166354207002392
-
K.E. Gantlett J.N. Weber Q.J. Sattentau 2007 Antiviral. Res. 75 188 197 17408760 10.1016/j.antiviral.2007.03.004 1:CAS:528:DC%2BD2sXmsFKhtrY%3D (Pubitemid 46898648)
-
(2007)
Antiviral Research
, vol.75
, Issue.3
, pp. 188-197
-
-
Gantlett, K.E.1
Weber, J.N.2
Sattentau, Q.J.3
-
14
-
-
4544299731
-
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses
-
DOI 10.1016/j.virol.2004.07.021, PII S0042682204004945
-
S.M. Wolinsky R.S. Veazey K.J. Kunstman P.J. Klasse J. Dufour A.J. Marozsan M.S. Springer J.P. Moore 2004 Virology 328 19 29 15380354 10.1016/j.virol.2004.07.021 1:CAS:528:DC%2BD2cXnslehtbs%3D (Pubitemid 39221908)
-
(2004)
Virology
, vol.328
, Issue.1
, pp. 19-29
-
-
Wolinsky, S.M.1
Veazey, R.S.2
Kunstman, K.J.3
Klasse, P.J.4
Dufour, J.5
Marozsan, A.J.6
Springer, M.S.7
Moore, J.P.8
-
15
-
-
19744379597
-
-
15823507 1:CAS:528:DC%2BD2MXks1Ghs7Y%3D
-
S. Liu H. Lu Q. Zhao Y. He J. Niu A.K. Debnath S. Wu S. Jiang 2005 Biochim. Biophys. Acta 1723 270 281 15823507 1:CAS:528:DC%2BD2MXks1Ghs7Y%3D
-
(2005)
Biochim. Biophys. Acta
, vol.1723
, pp. 270-281
-
-
Liu, S.1
Lu, H.2
Zhao, Q.3
He, Y.4
Niu, J.5
Debnath, A.K.6
Wu, S.7
Jiang, S.8
-
16
-
-
72049113673
-
-
H. Haim Z. Si N. Madani L. Wang J.R. Courter A. Princiotto A. Kassa M. DeGrace K. McGee-Estrada M. Mefford D. Gabuzda A.B. Smith III J. Sodroski 2009 PLoS Pathogens 5 5 1 13
-
(2009)
PLoS Pathogens
, vol.5
, Issue.5
, pp. 1-13
-
-
Haim, H.1
Si, Z.2
Madani, N.3
Wang, L.4
Courter, J.R.5
Princiotto, A.6
Kassa, A.7
Degrace, M.8
McGee-Estrada, K.9
Mefford, M.10
Gabuzda, D.11
Smith Iii, A.B.12
Sodroski, J.13
-
17
-
-
0042924181
-
Virus entry as a target for anti-HIV intervention
-
DOI 10.2174/0929867033457098
-
J.A. Esté 2003 Curr. Med. Chem. 10 1617 1632 12871111 10.2174/0929867033457098 (Pubitemid 37038589)
-
(2003)
Current Medicinal Chemistry
, vol.10
, Issue.17
, pp. 1617-1632
-
-
Este, J.A.1
-
18
-
-
0030813482
-
Sulfated polysaccharides extracted from sea algae as potential antiviral drugs
-
DOI 10.1016/S0306-3623(96)00563-0, PII S0306362396005630
-
M. Witvrouw E. Clercq 1997 Gen. Pharm. 29 4 497 511 10.1016/S0306- 3623(96)00563-0 1:CAS:528:DyaK2sXmsVGrs7g%3D (Pubitemid 27421412)
-
(1997)
General Pharmacology
, vol.29
, Issue.4
, pp. 497-511
-
-
Witvrouw, M.1
De Clercq, E.2
-
25
-
-
78650638887
-
-
21339954 10.3390/md8122871 1:CAS:528:DC%2BC3cXhsFKjsr%2FI
-
T.-S. Vo S.-K. Kim 2010 Mar. Drugs 8 2871 2892 21339954 10.3390/md8122871 1:CAS:528:DC%2BC3cXhsFKjsr%2FI
-
(2010)
Mar. Drugs
, vol.8
, pp. 2871-2892
-
-
Vo, T.-S.1
Kim, S.-K.2
-
28
-
-
24044513314
-
Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities
-
DOI 10.1093/glycob/cwi031
-
H. Liu M. Geng X. Xin F. Li Z. Zhang J. Li J. Ding 2005 Glycobiology 15 5 501 510 15616125 10.1093/glycob/cwi031 1:CAS:528:DC%2BD2MXjsl2hu7w%3D (Pubitemid 41214395)
-
(2005)
Glycobiology
, vol.15
, Issue.5
, pp. 501-510
-
-
Liu, H.1
Geng, M.2
Xin, X.3
Li, F.4
Zhang, Z.5
Li, J.6
Ding, J.7
-
29
-
-
2342449312
-
-
14529524 10.2174/1568026033451790 1:CAS:528:DC%2BD3sXmsFylt74%3D
-
L.-A. Tziveleka C. Vagias V. Roussis 2003 Curr. Top. Med. Chem. 3 1512 1535 14529524 10.2174/1568026033451790 1:CAS:528:DC%2BD3sXmsFylt74%3D
-
(2003)
Curr. Top. Med. Chem.
, vol.3
, pp. 1512-1535
-
-
Tziveleka, L.-A.1
Vagias, C.2
Roussis, V.3
-
33
-
-
0033792661
-
-
11040059 1:CAS:528:DC%2BD3cXnslKgtL4%3D
-
M. Witvrouw V. Fikkert W. Pluymers B. Matthews K. Mardel D. Schols J. Raff Z. Debyser E. Clercq G. Holan C. Pannecouque 2000 Mol. Pharmacol. 58 5 1100 1108 11040059 1:CAS:528:DC%2BD3cXnslKgtL4%3D
-
(2000)
Mol. Pharmacol.
, vol.58
, Issue.5
, pp. 1100-1108
-
-
Witvrouw, M.1
Fikkert, V.2
Pluymers, W.3
Matthews, B.4
Mardel, K.5
Schols, D.6
Raff, J.7
Debyser, Z.8
Clercq, E.9
Holan, G.10
Pannecouque, C.11
-
34
-
-
4644235778
-
Glycodendritic structures: Promising new antiviral drugs
-
DOI 10.1093/jac/dkh399
-
J. Rojo R. Delgardo 2004 J. Antimicrob. Chemother. 54 579 581 15308605 10.1093/jac/dkh399 1:CAS:528:DC%2BD2cXnsVyht70%3D (Pubitemid 39263896)
-
(2004)
Journal of Antimicrobial Chemotherapy
, vol.54
, Issue.3
, pp. 579-581
-
-
Rojo, J.1
Delgado, R.2
-
36
-
-
0344253721
-
Interaction of sulfonated anionic porphyrins with HIV glycoprotein gp120: Photodamages revealed by inhibition of antibody binding to V3 and C5 domains
-
DOI 10.1016/S0166-3542(03)00176-1
-
J. Dairou C. Vever-Bizet D. Braulta 2004 Antiviral. Res. 61 37 47 14670592 10.1016/S0166-3542(03)00176-1 1:CAS:528:DC%2BD3sXps1GrtL8%3D (Pubitemid 37508527)
-
(2004)
Antiviral Research
, vol.61
, Issue.1
, pp. 37-47
-
-
Dairou, J.1
Vever-Bizet, C.2
Brault, D.3
-
38
-
-
20944444371
-
Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
-
DOI 10.1128/JVI.79.10.6122-6133.2005
-
Q. Yang A.G. Stephen J.W. Adelsberger P.E. Roberts W. Zhu M.J. Currens Y. Feng B.J. Crise R.J. Gorelick A.E. Rein R.J. Fisher R.H. Shoemaker S. Sei 2005 J. Virol. 79 10 6122 6133 15857997 10.1128/JVI.79.10.6122-6133.2005 1:CAS:528:DC%2BD2MXkt1WitLs%3D (Pubitemid 40617217)
-
(2005)
Journal of Virology
, vol.79
, Issue.10
, pp. 6122-6133
-
-
Yang, Q.-E.1
Stephen, A.G.2
Adelsberger, J.W.3
Roberts, P.E.4
Zhu, W.5
Currens, M.J.6
Feng, Y.7
Crise, B.J.8
Gorelick, R.J.9
Rein, A.R.10
Fisher, R.J.11
Shoemaker, R.H.12
Sei, S.13
-
39
-
-
0037413385
-
Enhanced transport of a novel anti-HIV agent - Cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers
-
DOI 10.1016/S0378-5173(02)00523-9, PII S0378517302005239
-
C. Udata J. Patel D. Pal E. Hejchman M. Cushman A.K. Mitra 2003 Int. J. Pharm. 250 157 168 12480282 10.1016/S0378-5173(02)00523-9 1:CAS:528: DC%2BD38Xpt12qs7c%3D (Pubitemid 35447946)
-
(2003)
International Journal of Pharmaceutics
, vol.250
, Issue.1
, pp. 157-168
-
-
Udata, C.1
Patel, J.2
Pal, D.3
Hejchman, E.4
Cushman, M.5
Mitra, A.K.6
-
40
-
-
0029969048
-
Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid
-
DOI 10.1023/A:1016059008464
-
S. Venkatesh J. Li Y. Xu R. Vishnuvajjala B.D. Anderson 1996 Pharm. Res. 13 10 1453 1459 8899834 10.1023/A:1016059008464 1:CAS:528:DyaK28XmsVyksrk%3D (Pubitemid 26356945)
-
(1996)
Pharmaceutical Research
, vol.13
, Issue.10
, pp. 1453-1459
-
-
Venkatesh, S.1
Li, J.2
Xu, Y.3
Vishnuvajjala, R.4
Anderson, B.D.5
-
41
-
-
0034048588
-
Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain
-
DOI 10.1016/S0968-0896(99)00269-2, PII S0968089699002692
-
A. Casimiro-Garcia E. Clercq C. Pannecouque 2000 Bioorg. Med. Chem. 8 191 200 10968278 10.1016/S0968-0896(99)00269-2 1:CAS:528:DC%2BD3cXht1GrtLk%3D (Pubitemid 30125668)
-
(2000)
Bioorganic and Medicinal Chemistry
, vol.8
, Issue.1
, pp. 191-200
-
-
Casimiro-Garcia, A.1
De Clercq, E.2
Pannecouque, C.3
Witvrouw, M.4
Stup, T.L.5
Turpin, J.A.6
Buckheit Jr., R.W.7
Cushman, M.8
-
42
-
-
0029065930
-
-
7853337 10.1021/jm00003a007 1:CAS:528:DyaK2MXjt1Sjsr4%3D
-
M. Cushman W.M. Golebiewski Y. Pommier A. Mazumder D. Reymen E. Clercq L. Graham W.G. Rice 1995 J. Med. Chem. 38 443 452 7853337 10.1021/jm00003a007 1:CAS:528:DyaK2MXjt1Sjsr4%3D
-
(1995)
J. Med. Chem.
, vol.38
, pp. 443-452
-
-
Cushman, M.1
Golebiewski, W.M.2
Pommier, Y.3
Mazumder, A.4
Reymen, D.5
Clercq, E.6
Graham, L.7
Rice, W.G.8
-
43
-
-
0033812685
-
-
10999491 10.1016/S0960-894X(00)00417-0 1:CAS:528:DC%2BD3cXmtF2htLw%3D
-
G.C. Paul E. Clercq C. Pannecouque M. Witvrouw T.L. Loftus J.A. Turpin R.W. Buckheit M. Cushman 2000 Bioorg. Med. Chem. Lett. 10 2149 2151 10999491 10.1016/S0960-894X(00)00417-0 1:CAS:528:DC%2BD3cXmtF2htLw%3D
-
(2000)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 2149-2151
-
-
Paul, G.C.1
Clercq, E.2
Pannecouque, C.3
Witvrouw, M.4
Loftus, T.L.5
Turpin, J.A.6
Buckheit, R.W.7
Cushman, M.8
-
44
-
-
0033587023
-
Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency
-
DOI 10.1021/jm980727m
-
M. Cushman S. Insaf G. Paul J.A. Ruell E. Clercq D. Schols C. Pannecouque M. Witvrouw C.A. Schaeffer J.A. Turpin K. Williamson W.G. Rice 1999 J. Med. Chem. 42 1767 1777 10346929 10.1021/jm980727m 1:CAS:528:DyaK1MXis1Wgs78%3D (Pubitemid 29244970)
-
(1999)
Journal of Medicinal Chemistry
, vol.42
, Issue.10
, pp. 1767-1777
-
-
Cushman, M.1
Insaf, S.2
Paul, G.3
Ruell, J.A.4
De Clercq, E.5
Schols, D.6
Pannecouque, C.7
Witvrouw, M.8
Schaeffer, C.A.9
Turpin, J.A.10
Williamson, K.11
Rice, W.G.12
-
45
-
-
0035283023
-
Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores
-
DOI 10.1021/jm000290u
-
K.C. Santhosh G.C. Paul E. Clercq C. Pannecouque M. Witvrouw T.L. Loftus J.A. Turpin R.W. Buckheit M. Cushman 2001 J. Med. Chem. 44 703 714 11262081 10.1021/jm000290u 1:CAS:528:DC%2BD3MXksVylsw%3D%3D (Pubitemid 32171667)
-
(2001)
Journal of Medicinal Chemistry
, vol.44
, Issue.5
, pp. 703-714
-
-
Santhosh, K.C.1
Paul, G.C.2
De Clercq, E.3
Pannecouque, C.4
Witvrouw, M.5
Loftus, T.L.6
Turpin, J.A.7
Buckheit Jr., R.W.8
Cushman, M.9
-
46
-
-
0034694347
-
-
10.1016/S0960-894X(00)00515-1
-
K.C. Santosh E. Clercq C. Pannecouque M. Witvrouw T.L. Loftus J.A. Turpin R.W. Buckheit M. Cushman 2000 Bioorg. Med. Chem. Lett. 10 2505 2508 10.1016/S0960-894X(00)00515-1
-
(2000)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 2505-2508
-
-
Santosh, K.C.1
Clercq, E.2
Pannecouque, C.3
Witvrouw, M.4
Loftus, T.L.5
Turpin, J.A.6
Buckheit, R.W.7
Cushman, M.8
-
47
-
-
0030033216
-
Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements
-
DOI 10.1021/jm950666h
-
R.F. Keyes W.M. Golebiewski M. Cushman 1996 J. Med. Chem. 39 508 514 8558520 10.1021/jm950666h 1:CAS:528:DyaK28XmvVyq (Pubitemid 26041463)
-
(1996)
Journal of Medicinal Chemistry
, vol.39
, Issue.2
, pp. 508-514
-
-
Keyes, R.F.1
Golebiewski, W.M.2
Cushman, M.3
-
48
-
-
0037811018
-
HIV coreceptors: Role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors
-
DOI 10.1016/S0005-2736(03)00162-7
-
M. Zaitseva K. Peden H. Golding 2003 Biochim. Biophys. Acta 1614 51 61 12873765 10.1016/S0005-2736(03)00162-7 1:CAS:528:DC%2BD3sXlsVaisrY%3D (Pubitemid 36851602)
-
(2003)
Biochimica et Biophysica Acta - Biomembranes
, vol.1614
, Issue.1
, pp. 51-61
-
-
Zaitseva, M.1
Peden, K.2
Golding, H.3
-
49
-
-
33744761177
-
Cellular entry of HIV: Evaluation of therapeutic targets
-
DOI 10.2174/138161206777442155
-
S. Pöhlmann J.D. Reeves 2006 Curr. Pharm. Des. 12 1963 1973 16787241 10.2174/138161206777442155 (Pubitemid 43821686)
-
(2006)
Current Pharmaceutical Design
, vol.12
, Issue.16
, pp. 1963-1973
-
-
Pohlmann, S.1
Reeves, J.D.2
-
50
-
-
33646070923
-
-
16611075 10.2174/092986706776361030 1:CAS:528:DC%2BD28Xislygsb0%3D
-
J.T. Leonard K. Roy 2006 Curr. Med. Chem. 13 911 934 16611075 10.2174/092986706776361030 1:CAS:528:DC%2BD28Xislygsb0%3D
-
(2006)
Curr. Med. Chem.
, vol.13
, pp. 911-934
-
-
Leonard, J.T.1
Roy, K.2
-
51
-
-
33749535051
-
HIV-1 entry inhibitors: Classes, applications and factors affecting potency
-
DOI 10.2174/157016206778560081
-
J. Sterjovski M.J. Churchill S.L. Wesseling P.R. Gorry 2006 Curr. HIV Res. 4 387 400 17073614 10.2174/157016206778560081 1:CAS:528: DC%2BD28XhtVCltb%2FO (Pubitemid 44524440)
-
(2006)
Current HIV Research
, vol.4
, Issue.4
, pp. 387-400
-
-
Sterjovski, J.1
Churchill, M.J.2
Wesselingh, S.L.3
Gorry, P.R.4
-
52
-
-
0034595078
-
A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity
-
DOI 10.1006/bbrc.2000.2411
-
S. Jiang A.K. Debnath 2000 Biochem. Biophys. Res. Commun. 270 1 153 157 10733920 10.1006/bbrc.2000.2411 1:CAS:528:DC%2BD3cXhvFClsrg%3D (Pubitemid 30440408)
-
(2000)
Biochemical and Biophysical Research Communications
, vol.270
, Issue.1
, pp. 153-157
-
-
Jiang, S.1
Debnath, A.K.2
-
53
-
-
27644505400
-
The anti-HIV activity of ADS-J1 targets the HIV-1 gp120
-
DOI 10.1016/j.virol.2005.08.007, PII S0042682205005015
-
M. Armand-Ugon I. Clotet-Codina C. Tintori F. Manetti B. Clotet M. Botta J.A. Este 2005 Virology 343 141 149 16168454 10.1016/j.virol.2005.08.007 1:CAS:528:DC%2BD2MXht1WjtbfL (Pubitemid 41572240)
-
(2005)
Virology
, vol.343
, Issue.1
, pp. 141-149
-
-
Armand-Ugon, M.1
Clotet-Codina, I.2
Tintori, C.3
Manetti, F.4
Clotet, B.5
Botta, M.6
Este, J.A.7
-
54
-
-
33846173312
-
HIV entry inhibitors targeting gp41: From polypeptides to small-molecule compounds
-
DOI 10.2174/138161207779313722
-
S. Liu S. Lu S. Jiang 2007 Curr. Pharm. Des. 13 143 162 17269924 10.2174/138161207779313722 1:CAS:528:DC%2BD2sXitVOhtrw%3D (Pubitemid 46085289)
-
(2007)
Current Pharmaceutical Design
, vol.13
, Issue.2
, pp. 143-162
-
-
Liu, S.1
Wu, S.2
Jiang, S.3
-
55
-
-
7244253012
-
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion
-
DOI 10.1128/AAC.48.11.4349-4359.2004
-
S. Jiang H. Lu S. Liu Q. Zhao Y. He A.K. Debnath 2004 Antimicrob. Agents Chemother. 48 11 4349 4359 15504864 10.1128/AAC.48.11.4349-4359.2004 1:CAS:528:DC%2BD2cXpvVyktr8%3D (Pubitemid 39434898)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.11
, pp. 4349-4359
-
-
Jiang, S.1
Lu, H.2
Liu, S.3
Zhao, Q.4
He, Y.5
Debnath, A.K.6
-
56
-
-
58149090406
-
-
19053778 10.1021/jm800869t 1:CAS:528:DC%2BD1cXhsVWisbrE
-
K. Liu H. Lu L. Hou Z. Qi C. Teixeira F. Barbault B.-T. Fan S. Liu S. Jiang L. Xie 2008 J. Med. Chem. 51 7843 7854 19053778 10.1021/jm800869t 1:CAS:528:DC%2BD1cXhsVWisbrE
-
(2008)
J. Med. Chem.
, vol.51
, pp. 7843-7854
-
-
Liu, K.1
Lu, H.2
Hou, L.3
Qi, Z.4
Teixeira, C.5
Barbault, F.6
Fan, B.-T.7
Liu, S.8
Jiang, S.9
Xie, L.10
-
58
-
-
33645781308
-
-
16569857 10.1128/AAC.50.4.1393-1401.2006 1:CAS:528:DC%2BD28XjvFOrs7s%3D
-
A. Vaillant J.-M. Juteau H. Lu S. Liu C. Lackman-Smith R. Ptak S. Jiang 2006 Antimicrob. Agents Chemother. 50 4 1393 1401 16569857 10.1128/AAC.50.4. 1393-1401.2006 1:CAS:528:DC%2BD28XjvFOrs7s%3D
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, Issue.4
, pp. 1393-1401
-
-
Vaillant, A.1
Juteau, J.-M.2
Lu, H.3
Liu, S.4
Lackman-Smith, C.5
Ptak, R.6
Jiang, S.7
-
61
-
-
0031775589
-
-
1:CAS:528:DyaK1cXks1yks7s%3D
-
O.M.Z. Howard T. Korte N.I. Tarasova M. Grimm J.A. Turpin W.G. Rice C.J. Michejda R. Blumenthal J.J. Oppenheim 1998 J. Leuk. Biol. 64 6 13 1:CAS:528:DyaK1cXks1yks7s%3D
-
(1998)
J. Leuk. Biol.
, vol.64
, pp. 6-13
-
-
Howard, O.M.Z.1
Korte, T.2
Tarasova, N.I.3
Grimm, M.4
Turpin, J.A.5
Rice, W.G.6
Michejda, C.J.7
Blumenthal, R.8
Oppenheim, J.J.9
-
62
-
-
14444282418
-
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application
-
DOI 10.1021/jm9801253
-
O.M.Z. Howard J.J. Oppenheim M.G. Hollingshead J.M. Covey J. Bigelow J.J. McCormack R.W. Buckheit D.J. Clanton J.A. Turpin W.G. Rice 1998 J. Med. Chem. 41 2184 2193 9632350 10.1021/jm9801253 1:CAS:528:DyaK1cXjtlyks7s%3D (Pubitemid 28285719)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.13
, pp. 2184-2193
-
-
Howard, O.M.Z.1
Oppenheim, J.J.2
Hollingshead, M.G.3
Covey, J.M.4
Bigelow, J.5
McCormack, J.J.6
Buckheit Jr., R.W.7
Clanton, D.J.8
Turpin, J.A.9
Rice, W.G.10
-
63
-
-
18644372005
-
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV
-
DOI 10.1016/S0960-894X(02)00606-6, PII S0960894X02006066
-
C.L. Lynch J.J. Hale R.J. Budhu A.L. Gentry S.G. Mills K.T. Chapman M. MacCoss L. Malkowitz M.S. Springer S.L. Gould J.A. DeMartino S.J. Siciliano M.A. Cascieri A. Carella G. Carver K. Holmes W.A. Schleif R. Danzeisen D. Hazuda J. Kessler J. Lineberger M. Miller E.A. Emini 2002 Bioorg. Med. Chem. Lett. 12 20 3001 3004 12270193 10.1016/S0960-894X(02)00606-6 1:CAS:528:DC%2BD38XntlagurY%3D (Pubitemid 35266778)
-
(2002)
Bioorganic and Medicinal Chemistry Letters
, vol.12
, Issue.20
, pp. 3001-3004
-
-
Lynch, C.L.1
Hale, J.J.2
Budhu, R.J.3
Gentry, A.L.4
Mills, S.G.5
Chapman, K.T.6
MacCoss, M.7
Malkowitz, L.8
Springer, M.S.9
Gould, S.L.10
DeMartino, J.A.11
Siciliano, S.J.12
Cascieri, M.A.13
Carella, A.14
Carver, G.15
Holmes, K.16
Schleif, W.A.17
Danzeisen, R.18
Hazuda, D.19
Kessler, J.20
Lineberger, J.21
Miller, M.22
Emini, E.A.23
more..
-
64
-
-
18644374488
-
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: Polar functionality and its effect on anti-HIV-1 activity
-
DOI 10.1016/S0960-894X(02)00605-4, PII S0960894X02006054
-
J.J. Hale R.J. Budhu S.G. Mills M. MacCoss S.L. Gould J.A. DeMartino M.S. Springer S.J. Siciliano L. Malkowitz W.A. Schleif D. Hazuda M. Miller J. Kessler R. Danzeisen K. Holmes J. Lineberger A. Carella G. Carver E.A. Emini 2002 Bioorg. Med. Chem. Lett. 12 20 2997 3000 12270192 10.1016/S0960-894X(02) 00605-4 1:CAS:528:DC%2BD38Xntlagurk%3D (Pubitemid 35266777)
-
(2002)
Bioorganic and Medicinal Chemistry Letters
, vol.12
, Issue.20
, pp. 2997-3000
-
-
Hale, J.J.1
Budhu, R.J.2
Mills, S.G.3
MacCoss, M.4
Gould, S.L.5
DeMartino, J.A.6
Springer, M.S.7
Siciliano, S.J.8
Malkowitz, L.9
Schleif, W.A.10
Hazuda, D.11
Miller, M.12
Kessler, J.13
Danzeisen, R.14
Holmes, K.15
Lineberger, J.16
Carella, A.17
Carver, G.18
Emini, E.A.19
-
65
-
-
18744416543
-
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: Modifications of the arylpropylpiperidine side chains
-
DOI 10.1016/S0960-894X(02)00829-6, PII S0960894X02008296
-
C.L. Lynch C.A. Willoughby J.J. Hale E.J. Holson R.J. Budhu A.L. Gentry K.G. Rosauer C.G. Caldwell P. Chen 2003 Biiorg. Med. Chem. Lett. 13 1 119 123 10.1016/S0960-894X(02)00829-6 1:CAS:528:DC%2BD38Xpt1Cqu78%3D (Pubitemid 35447697)
-
(2003)
Bioorganic and Medicinal Chemistry Letters
, vol.13
, Issue.1
, pp. 119-123
-
-
Lynch, C.L.1
Willoughby, C.A.2
Hale, J.J.3
Holson, E.J.4
Budhu, R.J.5
Gentry, A.L.6
Rosauer, K.G.7
Caldwell, C.G.8
Chen, P.9
Mills, S.G.10
MacCoss, M.11
Berk, S.12
Chen, L.13
Chapman, K.T.14
Malkowitz, L.15
Springer, M.S.16
Gould, S.L.17
DeMartino, J.A.18
Siciliano, S.J.19
Cascieri, M.A.20
Carella, A.21
Carver, G.22
Holmes, K.23
Schleif, W.A.24
Danzeisen, R.25
Hazuda, D.26
Kessler, J.27
Lineberger, J.28
Miller, M.29
Emini, E.A.30
more..
-
67
-
-
3543144738
-
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro
-
DOI 10.1128/JVI.78.16.8654-8662.2004
-
K. Maeda H. Nakata U. Koh T. Miyakawa H. Ogata Y. Takaoka S. Shibayama K. Sagawa D. Fukushima J. Moravek Y. Koyanagi H. Mitsuya 2004 J. Virol. 78 16 8654 8662 15280474 10.1128/JVI.78.16.8654-8662.2004 1:CAS:528:DC%2BD2cXmslSmtbg%3D (Pubitemid 39025131)
-
(2004)
Journal of Virology
, vol.78
, Issue.16
, pp. 8654-8662
-
-
Maeda, K.1
Nakata, H.2
Koh, Y.3
Miyakawa, T.4
Ogata, H.5
Takaoka, Y.6
Shibayama, S.7
Sagawa, K.8
Fukushima, D.9
Moravek, J.10
Koyanagi, Y.11
Mitsuya, H.12
-
68
-
-
15744391870
-
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor
-
DOI 10.1124/mol.104.008565
-
C. Watson S. Jenkinson W. Kazmierski T. Kenakin 2005 Mol. Pharmacol. 67 4 1268 1282 15644495 10.1124/mol.104.008565 1:CAS:528:DC%2BD2MXjtFWmsLg%3D (Pubitemid 40410427)
-
(2005)
Molecular Pharmacology
, vol.67
, Issue.4
, pp. 1268-1282
-
-
Watson, C.1
Jenkinson, S.2
Kazmierski, W.3
Kenakin, T.4
-
69
-
-
43049147574
-
-
10.1016/j.jmgm.2007.12.003 1:CAS:528:DC%2BD1cXlvVWntrY%3D
-
T. Wang Y. Duan 2008 J. Mol. Graphics Model. 26 1287 1295 10.1016/j.jmgm.2007.12.003 1:CAS:528:DC%2BD1cXlvVWntrY%3D
-
(2008)
J. Mol. Graphics Model.
, vol.26
, pp. 1287-1295
-
-
Wang, T.1
Duan, Y.2
|